Introduction {#S1}
============

With the aging of the population in China, the incidence rate of chronic internal carotid artery (ICA) occlusion (ICAO) is estimated to be substantial ([@B15]). ICAO is associated with a 6--14% annual risk of transient ischemic attack (TIA) or stroke, despite medical treatment ([@B5]; [@B18]), and a higher risk is present in patients without sufficient collateral compensation ([@B6]). The best treatment for symptomatic chronic ICAO is still controversial, surgical treatment could be indicated if pharmacotherapy fails or as prophylaxis therapy in high-risk patients. In earlier studies, extracranial-intracranial (EC-IC) artery bypass, as a low-flow bypass, showed no superiority over medical therapy and didn't reduce the risk of recurrence ipsilateral ischemic stroke ([@B3]; [@B19]). Carotid endarterectomy (CEA) and endovascular interventions (EI) are considered to be effective therapeutic approaches to recanalize the occluded ICA, but they have shown low success rates in previous studies ([@B17]; [@B14]; [@B2]). Hybrid surgery in which CEA for a proximal ICAO is combined with EI for a distal ICAO in one session is reportedly a feasible and effective procedure with a higher success rate ([@B21]; [@B9]; [@B12]).

In previous studies, hybrid surgery was performed to treat tandem disease of the carotid bifurcation and arch vessels, and a high success rate of 97% was achieved ([@B20]). Hybrid surgery is being increasingly performed for treatment of chronic ICAO. It can remove hard plaques and help endovascular devices to recognize and traverse the true lumen in the distal ICA simultaneously. In the present study, 55 patients with chronic occlusion of the ICA underwent hybrid operation procedures in the same operative session in a hybrid operating room. The patients' clinical information, radiologic characteristics, complications, and outcomes were analyzed, and factors affecting the success rate were investigated.

Materials and Methods {#S2}
=====================

Patient Selection {#S2.SS1}
-----------------

Consecutive patients with symptomatic chronic ICAO who underwent CEA in conjunction with EI from March 2016 to March 2019 were enrolled in this study. All patients who presented with ipsilateral ischemic symptoms had failed with maximal medical therapy. Medical therapy usually included dual antiplatelet or anticoagulation plus antiplatelet. Patients were diagnosed by Doppler ultrasound, computed tomography (CT) angiography (CTA), magnetic resonance (MR) angiography (MRA), and digital subtraction angiography (DSA). Chronic complete occlusion was defined as a duration of ≥4 weeks between diagnosis and treatment. The specific inclusion criteria were as follows: The patients had recurrent ipsilateral ischemic symptoms despite medical treatment, but had no new ischemic stroke (≥4 weeks); the ipsilateral middle cerebral artery was patent, and no smoke-like blood vessel was present; cerebral hemodynamics was impaired with 'misery perfusion' or in stage II hemodynamic failure, including increasing mean transit time (MTT more than 4 s), decreased cerebral blood flow (CBF) ratio (symptomatic side/asymptomatic side \<0.95) and increasing oxygen extraction fraction (OEF) ratio (ipsilateral side/contralateral side \>1.13) in preoperative perfusion CT (CTP)/MR imaging (MRI) or positron emission tomography (PET) ([@B19]; [@B15]); and the proximal occlusion of the ICA had no stump or tamper. The exclusion criteria were as follows: the presence of severe systemic disease that prevented surgery and anesthesia; the presence of heart disease (unstable angina or acute myocardial infarction), bleeding disorder, or a contraindication to aspirin, clopidogrel, heparin, or iodine contrast; and older patients with end-stage disease or in poor neurologic condition. This retrospective study was approved by the institutional review board, and written informed consent was obtained from all participants.

Preprocedure Management {#S2.SS2}
-----------------------

The DSA and CTA images were assessed by two neurosurgeons. The occlusion length, occlusion site, collateral circulation, clinical variables, and neurologic data were collected and analyzed ([Figures 1A](#F1){ref-type="fig"}, [2A](#F2){ref-type="fig"}, [3A](#F3){ref-type="fig"}). The occlusion length was measured from the occlusion proximal site to the distal reconstituted ICA on lateral angiographic image, ignoring potential curvature of the occluded segment. Brain perfusion MRI (MRP), CTP ([Figures 1E--H](#F1){ref-type="fig"}) or PET was performed to evaluate the cerebral hemodynamics and perfusion--diffusion mismatch. Patients received medical therapy that consisted of dual antiplatelet therapy with aspirin (100 mg/day) and clopidogrel (75 mg/day) for at least 5 days before surgery.

![Representative Case 1. A 67-year-old woman with right-sided limb weakness underwent hybrid surgery for internal carotid artery occlusion (ICAO). **(A)** Preoperative computed tomography angiography (CTA) confirmed total occlusion (arrow) of the right ICA without a stump and **(B)** with filling at the ophthalmic segment. **(C)** Digital subtraction angiography (anteroposterior view) showed successful recanalization after deployment of the stent. **(D)** CTA showed a patent ICA at 3 months after the surgery. **(E--L)** Preoperative and postoperative perfusion CT. Postoperative perfusion CT showed improvements in the **(I)** cerebral blood flow (CBF), **(K)** mean transit time (MTT), and **(L)** time to peak (TTP) after recanalization \[compared with low CBF in **(E)**, high MTT in **(G)**, and delayed TTP in **(H)**).](fnins-14-00392-g001){#F1}

![Representative Case 2. A 51-year-old man with left-sided limb weakness underwent hybrid surgery for internal carotid artery occlusion (ICAO). **(A)** Preoperative angiography showed right ICA occlusion (blue arrow) with filling at the cavernous segment (red arrow). Intraoperative angiography showed **(B)** an artificial stump after carotid endarterectomy (red arrow) and **(C)** successful recanalization after deployment of the stent. **(D)** Computed tomography angiography showed a patent ICA at 3 months after the surgery.](fnins-14-00392-g002){#F2}

![Representative Case 3. A 53-year-old man with right-sided limb weakness underwent hybrid surgery for internal carotid artery occlusion (ICAO). **(A)** Preoperative computed tomography angiography (CTA) showed left total ICAO (red arrow). Intraoperative angiography showed **(B)** an artificial stump (red arrow) after carotid endarterectomy and distal true lumen of ICA **(C)**. Successful recanalization **(E)** was achieved after balloon expansion **(D)** and deployment of the stent. **(F)** CTA showed a patent ICA at 3 months after the surgery.](fnins-14-00392-g003){#F3}

Hybrid Surgery Procedure {#S2.SS3}
------------------------

The recanalization procedure was performed in a hybrid operating room equipped with an angiographic fluoroscopy system. Under general anesthesia, all patients underwent standard CEA. A skin incision was made along the anterior border of the ipsilateral sternocleidomastoid muscle to explore the common carotid artery (CCA), ICA, and external carotid artery (ECA). An arteriotomy was made on the ICA bifurcation after clamping of the superior thyroid artery, CCA, ICA, and ECA. After removal of the atherosclerotic plaque ([Figures 2B](#F2){ref-type="fig"}, [3B](#F3){ref-type="fig"}), the ICA clamp was loosened to observe arterial backflow. If little or no blood backflow was present, the surgical wound was sutured with placement of drainage; this was followed by EI therapy via percutaneous transfemoral approach.

A size 8 French artery sheath was positioned via transfemoral approach, and angiography was performed to observe the patency of ICA and formation of dissection. At the same time, intravenous infusion of heparin was carried out intraoperatively to maintain activated clotting time of 200--250 s. A 8F guiding catheter was placed into CCA or ICA, and a 0.014-inch Transend microwire (Stryker Neurovascular, Fremont, CA, United States) or Pilot microwire (Abbott Vascular, Santa Clara, CA, United States) in combination with Echelon-10 microcatheter (Medtronic, Minneapolis, MN, United States) or Gateway balloon catheter (Stryker Neurovascular, Fremont, CA, United States) were used to penetrate through the occluded segment of ICA ([Figure 3C](#F3){ref-type="fig"}). After successfully reaching the distal true lumen of ICA, a Spider embolic protection device (ev3 Neurovascular, Irvine, CA, United States) was used if an adequate landing zone was identified, otherwise a Mo. Ma occlusion system (Medtronic, United States) was used to protect from embolization in cases with long or intracranial occlusion. Then a 2F or 3F Fogarty balloon catheter (Edwards Lifesciences Corp. Irvine, CA, United States) was sent into the distal true lumen to remove the thrombus, and this operation could be repeated two or three times. If no robust backflow of blood was present, a selective angiography was performed to evaluate the occlusion. Next, a Gateway balloon (Boston Scientific Corporation, Natick, MA, United States) dilation was performed distally ([Figure 3D](#F3){ref-type="fig"}), along with sterling Monorail angioplasty balloon (Boston Scientific, United States) to reconstruct the proximal carotid artery lesion, followed by deployment of a Wallstent (Boston Scientific, United States) for dissection or stenosis of cervical ICA, or Winspan stent (Boston Scientific, United States) and Enterprise stent (Codman Neuro, New Brunswick, NJ, United States) for distal lesion. Post dilation with balloon was performed if remnant stenosis within the stent was over 50%. Wiring was stopped if the futile attempt was more than 30 min. The recanalization was considered a success ([Figures 1C](#F1){ref-type="fig"}, [2C](#F3){ref-type="fig"}, [3E](#F3){ref-type="fig"}) if the residual diameter stenosis of occluded segment was less than 20%, and grade 3 antegrade flow was established by using Thrombolysis in Cerebral Infarction (TICI) Grade system ([@B1]), otherwise, the surgery was unsuccessful if no or little blood backflow was seen or endovascular equipment couldn't cross the occlusion.

Postoperative Management and Follow-Up {#S2.SS4}
--------------------------------------

A postoperative CT scan was performed to identify intracranial hemorrhage or new ischemic lesions, and the blood pressure was usually controlled at \<140/90 mmHg for 3 days. For patients without hypertension, the blood pressure was strictly controlled at \<120 mmHg. Aspirin (100 mg/day), clopidogrel (75 mg/day), and atorvastatin calcium (20 mg/day) tablets were taken for at least 3 months in patients with stent placement, and a single antiplatelet agent and atorvastatin calcium were thereafter taken for life. CTA ([Figures 1D](#F1){ref-type="fig"}, [2D](#F2){ref-type="fig"}, [3F](#F3){ref-type="fig"}), CTP ([Figures 1I--L](#F1){ref-type="fig"}) or MRP was performed at 3 months after the operation, and DSA was performed at 6--12 months and annually afterward. Recurrent ischemic symptoms, reocclusion, the modified Rankin scale (MRS) score, the Barthel index score, and the Mini-Mental State Examination (MMSE) score were documented during follow-up.

Statistical Analysis {#S2.SS5}
--------------------

The statistical analysis was performed using SPSS software 25.0 (IBM Corp., Armonk, NY, United States). Categorical variables are expressed as count (with percentage), and continuous variables are expressed as median or mean ± standard deviation. The paired *t* test (or *t* test) and χ^2^ test (or Fisher's exact test) were used to compare continuous variables and categorical variables, respectively. Multivariate logistic regression was performed to identify the factors influencing the recanalization rate. A *P* value of \<0.05 was considered statistically significant.

Results {#S3}
=======

In total, 55 patients (10 women and 45 men) with a mean age of 59.3 ± 8.8 years were enrolled in the study. The patients' demographic data are shown in [Table 1](#T1){ref-type="table"}. Of all 55 occluded ICAs, 43 were successfully recanalized with a success rate of 78.2%. All patients had a history of ischemic stroke or TIA. The median duration from diagnosis of occlusion to treatment was 100 days. The duration was significantly longer in the failure group than in the success group (median, 200 vs. 90 days, respectively; *P* \< 0.01), but other variables between two groups were not statistically different (*P* \> 0.05) ([Table 1](#T1){ref-type="table"}).

###### 

Baseline characteristics of patients.

  **Variables**             **Success group (*n* = 43)**   **Failure group (*n* = 12)**   **Total (*n* = 55)**   ***P* value**
  ------------------------- ------------------------------ ------------------------------ ---------------------- ---------------
  Age (years)               59.8 ± 7.7                     57.4 ± 12.2                    59.3 ± 8.8             0.532
  Gender                    0.430                                                                                
   Female                   9 (20.9)                       1 (8.3)                        10 (18.2)              
   Male                     34 (79.1)                      11 (91.7)                      45 (81.8)              
  Smoking                   25 (58.1)                      9 (75.0)                       34 (61.8)              0.336
  Drinking                  8 (18.6)                       2 (16.7)                       10 (18.2)              1.000
  Past history                                                                                                   
   Hypertension             30 (69.8)                      7 (58.3)                       37 (67.3)              0.733
   Diabetes                 19 (44.2)                      4 (33.3)                       23 (41.8)              0.742
   Hyperlipidemia           8 (18.6)                       0 (0.0)                        8 (14.5)               0.178
  Coronary heart disease    2 (4.7)                        0 (0.0)                        2 (3.6)                1.000
  Clinical presentation     0.7436                                                                               
   TIA                      18 (41.9)                      4 (33.3)                       22 (40.0)              
   Stroke                   25 (58.1)                      8 (66.7)                       33 (60.0)              
  Duration (days, median)   90                             200                            100                    0.002

Values are presented as mean ± standard deviation, median or

n

(%). TIA, transient ischemic attack.

CEA was performed in all patients at first; balloon dilation was subsequently performed in 5 and stent implantation in 38, a total of 66 stents were used. The guidewire failed to pass through the distal occluded segment in the failure group. The lesion characteristics are summarized in [Table 2](#T2){ref-type="table"}. The occlusion length was significantly greater in the failure than success group (7.5 ± 1.0 vs. 5.4 ± 1.5 cm, respectively; *P* \< 0.001). The success rates of distal ICA recanalization at the petrous segment or below, at the cavernous segment, and at the clinoid segment or above were 100, 33.3, and 14.3%, respectively (*P* \< 0.001).

###### 

Lesion characteristics and surgical types.

                                       **Success group (*n* = 43)**   **Failure group (*n* = 12)**   **Total (*n* = 55)**   ***P* value**
  ------------------------------------ ------------------------------ ------------------------------ ---------------------- ---------------
  Left lesions                         22 (51.2)                      6 (50)                         28 (50.9)              1.000
  Occlusion length (cm)                5.4 ± 1.5                      7.5 ± 1.0                      5.9 ± 1.7              \<0.001
  Level of distal ICA reconstitution   \<0.001                                                                              
   Petrous segment or below            39 (90.7)                      0 (0.0)                        39 (70.9)              
   Cavernous segment                   3 (7.0)                        6 (50.0)                       9 (16.4)               
   Clinoid segment or above            1 (2.3)                        6 (50.0)                       7 (12.7)               
  Surgical types                                                                                                            
   CEA + balloon dilation              5 (11.6)                       0 (0.0)                        5 (9.1)                
   CEA + stent implantation            38 (88.4)                      0 (0.0)                        38 (69.1)              
   CEA + EI (failed)                   0                              12 (100.0)                     12 (21.8)              

Values are presented as mean ± standard deviation, median or

n

(%). CEA, carotid endarterectomy; ICA, internal carotid artery. EI, endovascular intervention.

The postoperative complications and outcomes are shown in [Table 3](#T3){ref-type="table"}. After successful recanalization, one patient developed hyperperfusion syndrome with minor subarachnoid hemorrhage. Another patient developed laryngeal nerve injury after CEA procedure in the failure group. Thus, the overall periprocedural complication rate was 3.6%. After proper treatment, both patients recovered completely. During follow-up (median, 10.7 months; range, 4--25 months), one patient (2.3%) developed ICA reocclusion in the success group, and two patients with unsuccessful recanalization experienced a minor ischemic stroke on days 97 and 152, respectively. CTA or perfusion CT was scheduled at 3 months and DSA at 6--12 months. The pre-procedural MRS score, MMSE score, and Barthel index score were similar between success group and failure group ([Table 4](#T4){ref-type="table"}). In the success group, 35 of 43 (81.4%) patients showed improvement in their symptoms, and their MRS score significantly improved (*P* \< 0.001). Significantly different MRS score at 3 months follow-up was observed between groups (median, success group: 0 vs. failure group: 0.5, respectively; *P* \< 0.05). No significant difference was found in the other scores (*P* \> 0.05) ([Tables 3](#T3){ref-type="table"}, [4](#T4){ref-type="table"}).

###### 

Outcomes and postoperative complications.

                                **Success group (*n* = 43)**   **Failure group (*n* = 12)**                         
  ----------------------------- ------------------------------ ------------------------------ --------- ----- ----- -------
  MMSE score                    30                             30                             0.230     30    30    1.000
  MRS score                     1                              0                              \<0.001   1     0.5   0.806
  Barthel Index                 100                            100                            0.874     100   100   1.000
  Postoperative complications                                                                                       
   Hyperperfusion syndrome      1                              0                              --        0     0     --
   Laryngeal nerve injury       0                              0                              --        1     0     --
  Clinical outcome                                                                                                  
   Ischemic events              0                              0                              --        0     2     --
   Death                        0                              0                              --        0     0     --
   Reocclusion                  0                              1                              --        --    --    --

Values are presented as median or

n

. MMSE, Mini-Mental State Examination; MRS, modified Rankin scale. Ischemic events were defined as ischemic stroke, transient ischemic attack, or amaurosis fugax.

###### 

Neurocognitive and neurologic function among groups.

                               **Success group (*n* = 43)**   **Failure group (*n* = 12)**   ***P* value**
  ---------------------------- ------------------------------ ------------------------------ ---------------
  MMSE score                                                                                 
   Baseline                    30                             30                             0.170
   Post-procedure (3 months)   30                             30                             0.422
  MRS score                                                                                  
   Baseline                    1                              1                              0.901
   Post-procedure (3 months)   0                              0.5                            0.036
  Barthel index                                                                              
   Baseline                    100                            100                            0.694
   Post-procedure (3 months)   100                            100                            0.748

Values are presented as median.

The duration, occlusion length, and level of distal ICA reconstitution with a *P* value of \<0.05 were included in the multivariate logistic regression. The results demonstrated that the level of distal ICA reconstitution was the only independent factor affecting the success of hybrid surgery (*P* \< 0.05), with an odds ratio of 2.517 and 95% confidence interval of 1.1 to 139.723 ([Table 5](#T5){ref-type="table"}).

###### 

Factors affecting recanalization (multivariate analysis).

                                       **Odds ratio**   **95% CI**      ***P* value**
  ------------------------------------ ---------------- --------------- ---------------
  Duration                             0.012            0.993--1.032    0.207
  Occlusion length                     0.780            0.419--11.374   0.354
  Level of distal ICA reconstitution   2.517            1.1--139.723    0.042

CI, confidence interval; ICA, internal carotid artery.

Discussion {#S4}
==========

Chronic ICAO often leads to severe outcomes due to ischemic stroke in patients without sufficient collateral compensation. The OEF is a gold standard to assess the cerebral blood flow, If ipsilateral-to-contralateral OEF ratio is greater than 1.13 or symptomatic patients with stage I or II hemodynamic failure, surgical treatment is usually recommended ([@B19]; [@B10]). However, it is difficult to choose a viable surgical treatment. In recent years, hybrid surgery was proven to be a feasible and efficient treatment and increased the success rate of recanalization in patients with chronic long segment or tandem occlusion ([@B21]; [@B9]; [@B12]). The present study displayed the efficacy and safety of hybrid surgery and identified a predictor of successful recanalization.

The successful recanalization rate with a TICI score of 3 was 78.2%, which was higher than that of initial CEA or EI alone ([@B22]; [@B2]). The baseline characteristics and lesion characteristics (except the duration, occlusion length, and level of distal ICA reconstitution) were statistically homogeneous between the two groups ([Tables 1](#T1){ref-type="table"}, [2](#T2){ref-type="table"}). As some literature has reported, it is relatively straightforward to achieve recanalization for acute and subacute ICAO because the thrombus is soft and clot fibrosis does not occur ([@B16]). The clot develops fibrotic organization and extends gradually over time, which increases the difficulty of recanalization. In the present study, the longer duration of occlusion in the failure group (median, 200 days) supports the above-mentioned view, but recanalization could be achieved by using microwire with stiffer tip and catheter with a tapered tip, just as previous report ([@B9]). However, the procedure must be performed carefully with above endovascular devices because the vessel wall can be easily perforated. Multiple projections, navigation of microguidewire in the center of vessel with good control, and low-pressure segmental angiography can reduce the risk of perforation and dissection of vessel wall. In theory, it's difficult to negotiate the wire through the long ICAO due to the variable vessel course, and easily induces pseudoaneurysm formation and artery dissection, therefore, a longer occlusion of ICAO should reduce the technical success rate. The success group had a shorter occlusion lesion than the failure group, suggesting that a shorter lesion of ICAO increases the success of recanalization. In the present study, we classified occlusions by the level of distal ICA reconstitution ([Figures 1B](#F1){ref-type="fig"}, [2A](#F2){ref-type="fig"}) and found that the success rates of recanalization at the petrous segment or below, at the cavernous segment, and at the clinoid segment or above were 100, 33.3, and 14.3%, respectively (*P* \< 0.001). It seemed that recanalization rate of ICAO beyond petrous portion was lower, but [@B2] reported that recanalization rate of ICAO with distal ICA reconstitution beyond clinoid segment was significantly lower. We speculated that our result was related to the small sample size and selection of patient group, larger studies should be necessary in the future.

Other factors, such as the stump morphology, atherosclerosis, and calcification in the initial part of the ICA or CCA, have been found to influence success rate of EI ([@B2]), The ICAO is often caused by atherosclerosis, with harder or severe calcified plaques that may hinder guidewire crossing and increase the difficulty for recanalization. However, the atherosclerosis plaque and dense calcium burden are mainly located at the proximal portion of the ICA because of the complex hemodynamics of low shear stress, flow stasis and flow separation at this site, not throughout the entire length of occlusion ([@B7]). CEA can remove the hard plaque at the initial part of the ICA or at the carotid bifurcation and build an artificial stump, then distal occlusion segment of ICA with loose calcification may be easily traversed, so factors above might have little effect on outcome in this study. The factors that may influence recanalization success were analyzed by multivariate analysis ([Table 5](#T5){ref-type="table"}). Our findings demonstrated that the level of distal ICA reconstitution was the only independent predictor of success of hybrid surgery for ICAO. This indicates that a lower location of the ICAO is associated with a higher success rate of recanalization. A future clinical study should consider stratified randomization for each level of ICAO.

In this study, the probability of any stroke during the postoperative period and follow-up was 2.3%, which is lower than that in some other reports ([@B19]; [@B9]). Furthermore, no patient died and the complication rate was only 3.6%, indicating that a hybrid operation is a safe and efficient treatment. The incidence of complications is usually related to technical difficulties and uncertainties and excessive perfusion following recanalization. The patients' systolic blood pressure was usually controlled at \<140 mmHg after recanalization in our study, but it was strictly controlled at \<120 mmHg if excessive perfusion was detected or hypertension was absent. Some reports have shown that CTP can be performed to assess the cerebral perfusion state and discover excessive perfusion early ([@B12]), so a CTP was recommended after successful recanalization. A prominent technology-related complication is embolic events caused by distal migration of the thrombus during catheterization through the thrombus and balloon dilation or the deployment of the stent. Therefore, a distal embolic protection or proximal occlusion of CCA with occlusion balloon that could reverse blood flow was deployed to minimize the risk of embolic events in our study, so no embolic stroke or symptomatic stroke happened postoperatively. Among the patients with successful recanalization, the reocclusion rate at the 3-month follow-up was 2.3% (1/43), which is lower than that in some other studies ([@B11]; [@B9]). However, the reason was presumably related to the shorter interval time after surgery. In those reports, balloon predilatation before stent placement and the occlusion site may have influenced the maintenance of the recanalization ([@B11]; [@B9]).

In the present study, most patients (81.4%) showed improvement in their neurological symptoms and no patient had recurrent ischemia symptoms during 3-month follow-up after successful recanalization, but subjective improvement should not be used to evaluate the clinical success of the operation because of the natural development process of stroke. Previous studies have shown that successful treatment of ICAO may improve global cognitive function as well as attention and psychomotor processing speed ([@B13]; [@B4]). In those studies, a series of examinations and tests were performed to evaluate neurocognitive and neurologic function. With the exception of the MRS score, our findings were not statistically significant ([Tables 3](#T3){ref-type="table"}, [4](#T4){ref-type="table"}), but the potential effectiveness of hybrid surgery cannot be ruled out. In summary, the neurological improvement, absence of recurrent TIA or stroke, and patency of the ICA on the basis of recanalization should be considered to indicate the potential effectiveness of the procedure. Further studies should give overall consideration to this issue and should include a longer follow-up period.

How to choose the optimal treatment for symptomatic ICAO remains controversial. Although CEA alone cannot achieve recanalization of long segmental occlusion or tandem occlusion, it can build an artificial stump, angle, and shorter lesion to enable better penetration with the endovascular equipment. With retrograde filling to the supraclinoid segment, endovascular therapy should be performed when the occlusion of the ICA has a stump or is in the acute and subacute stages. Hybrid surgery is more appropriate in chronic cases when long or tandem occlusion of the ICA has an atherosclerotic plaque or calcification and has no stump, furthermore, it does not require MCA occlusion and therefore has an advantage over EC-IC artery bypass. For occlusion of the ICA without a stump and supraclinoid filling, extracranial--intracranial artery bypass could be a therapeutic choice. In a previous study, [@B8] reported that surgical embolectomy might be considered as an additional therapeutic strategy to treat ICA terminus occlusion. It might also be useful to recanalize tandem occlusion at the initial part and the terminus of the ICA in conjunction with CEA. In another study involving multimodality *in situ* recanalization in a hybrid operating room ([@B9]), EI was performed first for short occlusions or occlusions with a tapered residual root. Otherwise, CEA was chosen as the initial procedure. If the initial procedure failed, an alternative procedure was immediately performed. In that study, the hybrid procedure fully exhibited its advantage in terms of efficiency ([@B9]). Therefore, it is critical to evaluate the occlusion before this operation.

Limitations {#S4.SS1}
-----------

This study had several limitations. First, it was a retrospective study, and some defects in the study design cannot be ignored (e.g., small sample size, single-center design with enrollment of only Chinese patients, and use of only one hybrid surgical method). In addition, the skill of the surgeons could lead to bias. Second, a longer follow-up is needed to evaluate neurologic improvement, the patency of the ICA, and the efficacy of hybrid surgery. Third, further exploration of treatment is required for patients with unsuccessful recanalization. Further studies are needed to take these issues into consideration and confirm the efficacy of hybrid surgery.

Conclusion {#S5}
==========

Hybrid surgery might be a safe and efficient therapeutic method for symptomatic chronic ICAO, with favorable clinical outcomes and low periprocedural complications. The level of the distal ICA reconstitution may predict technical success. Therefore, it is prudent to recanalize the occlusion at the supraclinoid segment and with a long duration.
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